Metabolic Disorders Disrupt Radiotherapy-Immunotherapy Synergy
In the evolving landscape of cancer therapeutics, the intersection of radiotherapy and immunotherapy holds tremendous promise, particularly for patients battling metastatic non-small-cell lung cancer (mNSCLC)....